IndraLab

Statements



reach
"Knockdown of USP42 can significantly promote the osteogenic differentiation of hASCs in vitro and in vivo , and overexpression of USP42 significantly inhibits in vivo osteogenic differentiation of hASCs, and USP42 can provide a potential therapeutic target for bone tissue engineering."